- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Humana Inc (HUM)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: HUM (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $287.83
1 Year Target Price $287.83
| 6 | Strong Buy |
| 3 | Buy |
| 17 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -38.97% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 31.18B USD | Price to earnings Ratio 24.27 | 1Y Target Price 287.83 |
Price to earnings Ratio 24.27 | 1Y Target Price 287.83 | ||
Volume (30-day avg) 26 | Beta 0.47 | 52 Weeks Range 206.15 - 314.25 | Updated Date 12/25/2025 |
52 Weeks Range 206.15 - 314.25 | Updated Date 12/25/2025 | ||
Dividends yield (FY) 1.38% | Basic EPS (TTM) 10.68 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.02% | Operating Margin (TTM) 2.04% |
Management Effectiveness
Return on Assets (TTM) 4.58% | Return on Equity (TTM) 7.16% |
Valuation
Trailing PE 24.27 | Forward PE 19.23 | Enterprise Value 38399792879 | Price to Sales(TTM) 0.25 |
Enterprise Value 38399792879 | Price to Sales(TTM) 0.25 | ||
Enterprise Value to Revenue 0.3 | Enterprise Value to EBITDA - | Shares Outstanding 120273068 | Shares Floating 120036130 |
Shares Outstanding 120273068 | Shares Floating 120036130 | ||
Percent Insiders 0.21 | Percent Institutions 97.66 |
Upturn AI SWOT
Humana Inc

Company Overview
History and Background
Humana Inc. was founded in 1961 by Wendell Cherry and David Jones in Louisville, Kentucky, originally as Extendicare, a nursing home chain. It evolved into a healthcare company, changing its name to Humana in 1974. Key milestones include its significant expansion into managed care in the 1980s and 1990s, its initial public offering (IPO) in 1978, and its increasing focus on government-sponsored health plans like Medicare Advantage and Medicaid.
Core Business Areas
- Health Plan and Services: This segment encompasses Humana's core health insurance business, offering a wide range of health and supplemental insurance products across Medicare Advantage, Medicaid, commercial group, and individual plans. It includes medical, dental, vision, and pharmacy benefits, along with integrated care management services.
- Primary Care Operations: Humana operates its own primary care clinics through CenterWell, formerly known as Humana Integrated Health System. This segment focuses on providing direct patient care, aiming to improve health outcomes and reduce costs through a value-based care model.
Leadership and Structure
Humana is led by a Chief Executive Officer and a Board of Directors. The company is organized into various divisions and segments aligned with its business areas, including health plans, pharmacy solutions, and primary care.
Top Products and Market Share
Key Offerings
- Medicare Advantage Plans: Humana is a leading provider of Medicare Advantage plans, offering comprehensive health coverage for seniors and individuals with disabilities. As of Q4 2023, Humana had approximately 7.1 million Medicare Advantage members. Competitors include UnitedHealth Group (UnitedHealthcare), CVS Health (Aetna), Elevance Health (Anthem), and Centene.
- Medicaid Plans: The company offers Medicaid plans to low-income individuals and families, serving millions of members across various states. Market share data for specific Medicaid plans is highly localized, but key competitors include Centene, CVS Health (Aetna), Elevance Health (Anthem), and Molina Healthcare.
- Pharmacy Solutions (CenterWell Pharmacy): This segment provides prescription drug services, including mail-order and specialty pharmacy. It also offers a range of pharmacy benefit management services. While specific revenue figures for this product alone are not always broken out, it's a critical component of Humana's integrated offering. Competitors include Optum Rx (UnitedHealth Group), Express Scripts (CVS Health), and Caremark (CVS Health).
- Primary Care Services (CenterWell): Through its CenterWell brand, Humana offers a growing network of primary care and senior-focused clinics. The number of patients served is expanding rapidly as Humana invests in this area. Competitors include large physician groups, hospital-affiliated clinics, and other integrated health systems.
Market Dynamics
Industry Overview
The US healthcare industry is characterized by rapid technological advancement, increasing regulatory scrutiny, rising healthcare costs, and a growing demand for integrated care models and value-based payment systems. The shift towards government-sponsored programs like Medicare Advantage and Medicaid continues to be a significant trend.
Positioning
Humana is well-positioned as a major player in the government-sponsored health plan market, particularly Medicare Advantage, where it holds a significant market share. Its focus on integrated care, including its growing primary care footprint with CenterWell, provides a competitive advantage by allowing for better coordination of care and cost management. Humana's emphasis on serving seniors is a core strength.
Total Addressable Market (TAM)
The TAM for health insurance in the US is vast, encompassing millions of individuals across commercial, Medicare, and Medicaid segments. The Centers for Medicare & Medicaid Services (CMS) estimates total US health spending to be over $4.5 trillion annually. Humana is positioned to capture a significant portion of the Medicare and Medicaid TAM, with ongoing investments aimed at expanding its reach in these segments and its primary care offerings to address the broader healthcare needs of its member base.
Upturn SWOT Analysis
Strengths
- Strong market position in Medicare Advantage.
- Growing presence in primary care through CenterWell.
- Focus on integrated care models.
- Established brand recognition and customer loyalty.
- Significant scale and operational efficiency.
Weaknesses
- Heavy reliance on government-sponsored programs, making it susceptible to regulatory changes.
- Competition in the commercial insurance market is intense.
- Challenges in managing rising healthcare costs across all segments.
- Potential integration challenges with recent acquisitions and expanded services.
Opportunities
- Further expansion of CenterWell primary care services.
- Leveraging data analytics to improve care management and reduce costs.
- Partnerships with providers and employers for innovative care solutions.
- Growth in chronic care management programs.
- Potential for international expansion or new market entry (long-term).
Threats
- Changes in Medicare and Medicaid reimbursement rates and regulations.
- Increased competition from other large health insurers and non-traditional players.
- Cybersecurity risks and data breaches.
- Economic downturns impacting individual enrollment and affordability.
- Litigation and compliance risks.
Competitors and Market Share
Key Competitors
- UnitedHealth Group (UNH)
- CVS Health Corporation (CVS)
- Elevance Health Inc. (ELV)
- Centene Corporation (CNC)
- Molina Healthcare Inc. (MOH)
Competitive Landscape
Humana's competitive advantage lies in its deep expertise in Medicare Advantage and its integrated care model, particularly with its growing CenterWell primary care network. However, it faces intense competition from larger, more diversified healthcare companies like UnitedHealth Group, which also has a strong presence in managed care and healthcare services. CVS Health, with its integrated pharmacy and insurance operations, and Elevance Health, another major player in government-sponsored plans, are also formidable competitors. Humana's focus on seniors and its commitment to value-based care are key differentiators.
Major Acquisitions
Paragon Healthcare
- Year: 2022
- Acquisition Price (USD millions):
- Strategic Rationale: Acquired to enhance Humana's specialty pharmacy capabilities and expand its service offerings.
CenterWell (formerly Kindred at Home)
- Year: 2022
- Acquisition Price (USD millions): 7800
- Strategic Rationale: This acquisition significantly expanded Humana's home health and primary care services under the CenterWell brand, aligning with its strategy of providing integrated, value-based care and improving patient outcomes outside of traditional clinical settings.
Growth Trajectory and Initiatives
Historical Growth: Humana has experienced substantial historical growth, primarily driven by its strategic focus on Medicare Advantage and its expansion into government-sponsored health programs. The acquisition and organic growth of its primary care business, CenterWell, represent a more recent significant growth driver.
Future Projections: Analyst projections for Humana's future growth generally anticipate continued expansion in Medicare Advantage and Medicaid. The growth of its primary care segment is also expected to be a key contributor. Revenue growth is projected to remain steady, with a focus on improving profitability through operational efficiencies and value-based care initiatives.
Recent Initiatives: Recent strategic initiatives include the aggressive expansion of its CenterWell primary care footprint, investments in technology and data analytics to enhance care management and member experience, and strategic partnerships aimed at improving healthcare access and affordability.
Summary
Humana Inc. is a strong player in the US healthcare market, particularly in Medicare Advantage, leveraging its integrated care model and growing primary care presence. Its financial performance has been solid, with consistent revenue growth. The company's main strengths lie in its market leadership in government programs and its focus on seniors. However, Humana needs to carefully navigate regulatory changes and intense competition, while continuing to invest in its primary care expansion and technological advancements to maintain its competitive edge and ensure long-term profitability.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Humana Inc. Investor Relations
- U.S. Securities and Exchange Commission (SEC) Filings (10-K, 10-Q)
- Financial news outlets and industry reports (e.g., Bloomberg, Reuters, FierceHealthcare)
- Market research firms specializing in healthcare.
Disclaimers:
This information is for informational purposes only and should not be considered financial advice. Market share data and financial figures are estimates and may vary depending on the source and reporting period. All data is subject to change. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Humana Inc
Exchange NYSE | Headquaters Louisville, KY, United States | ||
IPO Launch date 1993-01-22 | President, CEO & Director Mr. James A. Rechtin M.B.A. | ||
Sector Healthcare | Industry Healthcare Plans | Full time employees 65680 | Website https://www.humana.com |
Full time employees 65680 | Website https://www.humana.com | ||
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. It offers medical care and supplemental benefit plans to individuals. The company also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, it provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; and military services, such as TRICARE T2017 East Region contract. Further, the company engages in the operation of pharmacy benefit manager business; operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. It sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

